|
Palo Alto, CA, February 17, 2004 — Telik, Inc. (Nasdaq:
TELK) announced that its quarterly conference call and webcast will
be held on Thursday, February 19, 2004 at 4:30 p.m. Eastern time
(1:30 p.m. Pacific time). The call will follow the release of Telik’s
fourth quarter and year end 2003 financial results earlier that
day.
Participants may access the live webcast via Telik’s website
at www.telik.com or by telephone at 612-332-0819. A replay of the
webcast will be available on the Telik website from approximately
8:30 p.m. Eastern time on February 19 through February 26, 2004.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases for which there is significant demand for new therapies.
The company’s most advanced drug development candidate is
TELCYTA™. Telik’s product candidates were discovered
using its proprietary technology, TRAP, which enables the rapid
and efficient discovery of small molecule drug candidates. Additional
information is available at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
